#car-t
#car-t

[ follow ]

#multiple-myeloma #immunotherapy #bispecific-antibodies #chronic-health-costs

Why a rare blood cancer has become a testing ground for cancer drug innovation

Multiple myeloma drives advanced gene and antibody therapies, transforming cancer into a chronic, high-cost condition while extending patient survival.

[ Load more ]

#car-t#car-t

Why a rare blood cancer has become a testing ground for cancer drug innovation

#car-t
#car-t